US Patent No: 6,252,131
Number of patents in Portfolio can not be more than 2000
Transgenic mammal having 5-HT3 transgene overexpression in the CMS
Stats
-
Jun 26, 2001
Issued date -
Oct 15, 1998
filing date -
09/172,625
serial no -
Expired
status
Importance
Loading Importance Indicators...
Abstract
The invention relates to transgenic mammals characterized by 5-HT.sub.3 receptor over-expression in the central nervous system (CNS) . The mammals have particular utility as models for studying the role of 5-HT.sub.3 receptors in the CNS, especially for the study of reward pathways for alcohol and other substances of abuse.
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 5,057,519 5-HT.sub.3 antagonists: use in reducing opiate tolerance | 15 | 1990 | |
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Dec 26, 2012 |
| Fee | Large entity fee | small entity fee | micro entity fee |
|---|---|---|---|
| Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
| Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |